Profit Investment Management, LLC Acadia Pharmaceuticals Inc Transaction History

Profit Investment Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 05, 2023	SELL	$20.84 - $33.47 $10,899 - $17,504	-523 Reduced 4.83%	10,306 $214,000
Q2 2023 Jul 10, 2023	SELL	$17.8 - $25.65 $3,186 - $4,591	-179 Reduced 1.63%	10,829 $259,000
Q2 2022 Jul 11, 2022	SELL	$13.01 - $27.22 $32,629 - $68,267	-2,508 Reduced 18.56%	11,008 $155,000
Q1 2022 Apr 20, 2022	BUY	$20.94 - $27.5 $38,613 - $50,710	1,844 Added 15.8%	13,516 $328,000
Q4 2021 Jan 19, 2022	SELL	$16.79 - $27.09 $8,395 - $13,545	-500 Reduced 4.11%	11,672 $273,000
Q4 2020 Jan 20, 2021	SELL	$41.04 - $56.79 $400,098 - $553,645	-9,749 Reduced 44.47%	12,172 $651,000
Q3 2020 Nov 09, 2020	BUY	$36.42 - $57.0 $798,362 - $1.25 Million	21,921 New	21,921 $905,000

280

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.65B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Profit Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Profit Investment Management, LLC with notifications on news.